REGENERON PHARMACEUTICALS, INC.
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Large accelerated filer
State of Incorporation NY
Business Address 777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY, 10591
Mailing Address 777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY, 10591
Phone 9148477000
Fiscal Year End 1231
EIN 133444607
Financial Overview
FY2025
$31.26B
Stockholders' Equity
$43.07
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 4 Insider stock transaction report | February 11, 2026 | View on SEC |
| 4 Insider stock transaction report | February 11, 2026 | View on SEC |
| 13F-HR Institutional investment holdings | February 6, 2026 | View on SEC |
| 10-K Annual financial report | February 4, 2026 | View on SEC |
| 8-K Current report of material events | January 30, 2026 | View on SEC |
| 8-K Current report of material events | January 12, 2026 | View on SEC |
| 4 Insider stock transaction report | January 8, 2026 | View on SEC |
| 4 Insider stock transaction report | January 6, 2026 | View on SEC |
| 4 Insider stock transaction report | January 6, 2026 | View on SEC |
| 4 Insider stock transaction report | January 6, 2026 | View on SEC |
Annual Reports
10-K February 4, 2026
- Robust R&D engine leading to two new drug approvals and three Phase 3 advancements in 2025.
- Strong financial position with $9.000 billion in cash and $6.800 billion in operating cash flow.
Insider Trading
STRONG SELL 3 insiders
26 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.